Cathepsins B and L are markers for clinically invasive types of meningiomas.

@article{Strojnik2001CathepsinsBA,
  title={Cathepsins B and L are markers for clinically invasive types of meningiomas.},
  author={Tadej Strojnik and Boris Židanik and Janko Kos and Tamara T Lah},
  journal={Neurosurgery},
  year={2001},
  volume={48 3},
  pages={598-605}
}
OBJECTIVE Meningiomas are benign neoplasms that derive from coverings of the brain. Approximately 10% of benign tumors progress into atypical, malignant tumors, thus constituting a subset of histopathologically benign tumors that are clinically invasive. The aim of this study was to evaluate cathepsins B and L and their inhibitors as new prognostic factors that could distinguish malignant from benign forms of meningiomas. METHODS Using immunohistochemical analysis and specific monoclonal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Similar Papers

Loading similar papers…